Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?
about
The application of the fibroblast activation protein α-targeted immunotherapy strategyBroad Spectrum Anticancer Activity of Myo-Inositol and Inositol HexakisphosphateClinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor CellsPlanarian regeneration in space: Persistent anatomical, behavioral, and bacteriological changes induced by space travel.A novel pathogenic classification of cancers.Long-range gap junctional signaling controls oncogene-mediated tumorigenesis in Xenopus laevis embryos.A cancer theory kerfuffle can lead to new lines of researchStromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival.Cancer Metastases: So Close and So Far.Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.Use of genetically encoded, light-gated ion translocators to control tumorigenesis.Co-evolution of tumor-associated macrophages and tumor neo-vessels during cervical cancer invasionStem Cell Differentiation Stage Factors from Zebrafish Embryo: A Novel Strategy to Modulate the Fate of Normal and Pathological Human (Stem) CellsPlasmacytoid dendritic cells, a role in neoplastic prevention and progression.Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals.SMT and TOFT: Why and How They are Opposite and Incompatible Paradigms.Emergent properties of a computational model of tumour growth.An Emergence Framework of Carcinogenesis.Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.The two faces of enhanced stroma: Stroma acts as a tumor promoter and a steric obstacle.Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities.Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
P2860
Q28073437-AC5AD420-3AD3-4AE4-84EC-04665C399B21Q28078208-4B1157B8-D168-453E-BB78-F5808AB40DB5Q28083973-9CACEF17-8390-4161-84B1-367808239187Q33793915-2D99E7CE-9E52-46F4-B5AA-4E3E0E34CB4EQ34659468-740D80CC-1242-4F69-AE9F-F42AD637B551Q34981782-A57FA1A1-CBE1-44B6-B031-7F4C0289E06BQ35078573-2C9AD08D-CD29-4D99-AAED-3E38DDB6CD93Q36247195-09BC2CC7-E60E-4FE1-85A7-F8430C2F8787Q36276549-E3C0836D-9F0A-4FF3-8892-78D8EC68DD9FQ36688972-A69B5501-C7F1-4B7E-A6A5-B7586178C1AFQ37190111-B5279775-85A3-4E98-8CA6-7EF28DD30895Q37288659-22A823F2-3012-474B-9915-D163B994B7F7Q37741546-8A54C221-FDF2-4AE0-B1C7-5D2F5DDBCCA9Q38294189-C37D328C-0758-40BB-93BB-F2ED3443E687Q38769921-DF958FCD-9724-4EC9-9553-A12E54513753Q38860764-6D282897-8437-4CD4-9C15-D83C3A6F1AACQ39603486-F0B7F46B-B3E1-456F-A14C-BADAEE014300Q41673282-9EA1D59D-8F7D-4831-9418-5F6905323E2BQ41701996-84588A0C-C7C3-407F-BB93-729FB9EE1D89Q48159638-4D8FFDA0-65B5-4F32-9AA7-7F0A8886911BQ49843607-E9302916-F5D2-4ECC-8F4D-E0727F2D3541Q50159459-6BB34360-1449-4E5D-8B9E-00F647452B19
P2860
Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?
@en
type
label
Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?
@en
prefLabel
Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?
@en
P2860
P356
P1476
Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?
@en
P2093
Alessandra Cucina
Mariano Bizzarri
P2860
P304
P356
10.1155/2014/934038
P407
P5008
P577
2014-06-12T00:00:00Z